Startups
Neuro42
San Francisco, California, United States
neuro42, Inc. is a San Francisco medical-technology company developing portable low-field magnetic resonance imaging, artificial intelligence and robotic guidance for neurological diagnosis and image-guided brain interventions. Its diagnostic MRI platform is FDA 510(k) cleared for neuroimaging; its interventional module is seeking regulatory clearance, so clearance is not asserted for the entire robotic platform. The company licenses MRI technology developed at Massachusetts General Hospital and describes more than 40 patents supporting its platform. Its published leadership and scientific/clinical advisors are recorded with source-qualified historical appointments where its directories differ. Financing records distinguish closed equity rounds, undisclosed personal investments and later offering disclosures under review.
Founded 2020
Team
 Abhay SananAdvisor |
 Abhita BatraChief Strategy Officer · Board Director (SEC2024 filing; current status unverified) |
 Amit VohraPresident & CEO · Board Director (SEC2024 filing; current status unverified) |
 Amrith JamoonaAdvisor |
 Ben InglisAdvisor |
 Clarissa CooleyAdvisor |
 Erika PetersenAdvisor |
 Fred MollStrategic Advisor (announced October 2023; current status unverified) |
 Ghoncheh AmouzandehMRI Scientist (published2022; current operating status unverified) |
 Haidong PengSenior VP of MRI · Contact Principal Investigator, NIH U44NS136026 (2026 award) |
 Heather SpaderAdvisor |
 James KramerSenior VP of Robotics (earlier published directory; current status unverified) |
 Jason StockmannAdvisor |
| Joyce YeSoftware Engineer (published2022; current operating status unverified) |
| Juan LiuMRI Scientist (published2022; current operating status unverified) |
Krishna R. BhupalBoard Director (announced October 2023; current status unverified) |
 Lawrence WaldAdvisor |
 Mark D’EspositoAdvisor |
 Michael LawtonAdvisor |
 Mitchel BergerAdvisor |
| Nguyên PhạmElectrical Engineer (published2022; current operating status unverified) |
 Nikhil SadhwaniChief Development Officer |
 P. David AdelsonAdvisor |
Rahul TalwarBoard Director (SEC September2024 filing; current status unverified) |
Shibu GangadharanExecutive Officer (SEC June2024 filing; current status unverified) |
| Sree Poojitha YerramsettiRF Engineer (published2022; current operating status unverified) |
| Xiaowei ZouMRI Scientist (published2022; current operating status unverified) · Co-Principal Investigator, NIH U44NS136026 (2026 award) |